Part 2 of this topic can be found here Inherited Retinal Disease (IRD) is the leading cause of blindness certification in the working age population (age 16-64 years) in England and Wales and the second most common in childhood [1]....
An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...
1 February 2016
| Fiona Harris, Spyridon Chalkiadakis, Simon Taylor (Prof)
|
EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...
The authors present guidelines on current diagnostic and therapeutic procedures in the management of DMO. Fluorescein angiography (FA) and optical coherence tomography (OCT) are recommended before starting treatment to help diagnose and stage DMO, and can be repeated if there...
I am a big fan of books which provide a historical context to some of the greatest wonders and challenges that we face. Siddarhtha Mukherjee does this well in Emperor of All Maladies (2010), where he explores the story of...
The authors share how a partnership between Mombasa and Southampton has enabled Kenyan healthcare professionals from four institutions to innovate and work as a group to improve infection prevention and control. Infection prevention and control (IPC) is a cornerstone of...
In the next of our articles celebrating 25 years of Eye News, the authors look at how the retina specialty has changed over this time and ask what the future might hold. Retinal disease management has benefited from great advances...
The Oxford Ophthalmological Congress CIO (the OOC)Charity no. 1181776Invitation to Tender for Conference Organisation & Event Management Services The Oxford Ophthalmological Congress is an historic meeting, in its 103rd year, and the second largest ophthalmological meeting held in the UK....
The Royal National Institute of Blind People (RNIB) has appointed Sir Jim Harra to take up the roles of Vice Chair of the Board of Trustees and Chair of the Governance, Nominations and Remuneration Committee. Jim was previously a Permanent...
Numerous studies have demonstrated that topical medications and preservatives used for the management of glaucoma can induce significant histopathologic and inflammatory changes in the ocular surface. This study describes an increased expression of major histocompatibility complex class II antigen HLA-DR,...
The purpose of this study was to evaluate the effect of improved control with part-time occlusion treatment on the final postoperative surgical outcome in patients with intermittent exotropia. Eighty-nine patients were recruited who had unilateral lateral rectus recess / reset...